Clinical Trial Update: Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

View source ↗

Summary

This clinical trial analyzes resistance to immune checkpoint inhibitors in non-small cell lung cancer. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-Small Cell Lung Cancer | Status: RECRUITING